High mobility group nucleosomal binding domain 2 pseudogene 16 (HMGN2P16)

High mobility group nucleosomal binding domain 2 pseudogene 16 (HMGN2P16) is a processed pseudogene located on human chromosome 5. Pseudogenes like HMGN2P16 are highly homologous to their ancestral protein-coding genes (in this case, high mobility group nucleosomal binding domain 2) but contain mutations or genetic modifications that prevent the production of a functional protein. Pseudogenes may be transcribed into non-coding RNAs, which can act as regulators of their parent gene's expression at the RNA level, potentially influencing biological processes via mechanisms such as RNA interference, competition for microRNAs, or alteration of mRNA stability. However, for HMGN2P16 specifically, no direct evidence supports a functional role, disease association, or therapeutic targeting. It serves primarily as a genomic element of evolutionary interest and is not currently used as a drug target, therapeutic biomarker, or clinical diagnostic marker.

Other names

HMGN2LEm:AL513423.2

Drugs do not target this pseudogene. Mechanisms of pseudogene function generally include RNA interference, miRNA decoy, or modulation of gene expression.